Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial.

CONCLUSION: EAT progression from baseline was significantly smaller with SVL than with CPiB, although the difference between treatments was not statistically significant, probably due to the small sample size. Change in serum lipids and markers of inflammation did not predict EAT progression.
PMID: 27102490 [PubMed - as supplied by publisher]

Source: Journal of Nephrology - April 20, 2016 Category: Urology & Nephrology Authors: Ko SM, Zhang C, Chen Z, D'Marco L, Bellasi A, Stillman AE, Block G, Raggi P Tags: J Nephrol Source Type: research